General Discussion, page-7

VHT capital raised 50 mil AUS to fund future growth and the acquisition of MRS for 21 mil AUS. MRS has 20% of US breast screening market to go with Volpara's 7%. I'd say this was a very cheap acquisition, based on the return Volpara can generate through this acquisition. It would take several years of growth capital to achieve this % market saturation. A very smart move from a smart NZ based company. The FDA is about to update it's density rating on breast screenings for US woman in the next couple of months. Volpara is a leader in this area with secure patents in place. Volpara has successfully increased institutional holding twice this year with little pickings for retail investors. When you need to raise capital for future investments, whose got the big capital ready? This company is figuring of biggering and biggering and making more money which everyone, everyone needs!!! SP has a floor at 1.6$. I'm biding my time looking for the spot. I've been planning when others have been playing. I've been buying when others are selling. This game is just warming up.